Pharmafile Logo

Creative Bioarray

Located at Long Island, New York, Creative Bioarray was founded as biomedical company focused on providing comprehensive biotechnology and pharmaceutical array services and products for high-throughput analysis. Creative Bioarray uniquely pioneers the development of high quality tissue, antibody, protein and cell array technology to efficiently analyze the concurrent expression and function of proteins involved in inflammation, angiogenesis, apoptosis, cell growth, and signal transduction from a single biological sample.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Company Details

45-16 Ramsey Road Shirley, New York, NY 11967, United States
+1 631 624 4882

 Latest Content from PMHub 

Lucid Group Experience the Magic of Mindfulness, Meditation and Massage

This time of year can be busier than normal. Lucid Group understand the importance of taking some time out to relax and unwind. That's why yesterday, relaxation, meditation and mindfulness...

Are you using Patient-Reported Outcomes (PROs) in your oncology trials? If not, why not?

A recent blog, published by Sarah Tressel Gary and Rinah Yamamoto called “Patient-Reported Outcome Data in Oncology Trials - Part 2: Clinical Benefit and Patient Preference”, has sparked our interest....

Bedrock’s on fire for Wellbeing Week

Press Releases | November 26, 2019 | Resonant Group

Bedrock creates a positive working environment to enable individuals and our business to thrive.

WHITE PAPER: Patient nonadherence – the $637bn paradox

White Papers and Resources | November 25, 2019 | IGNIFI

What’s not changed for 50 years, kills 200,000 Europeans annually, costs pharma $637 billion and the NHS over £500 million a year? We’ll tell you.

Spotlight interview: 15 minutes on insights and market research in pharma

Neil Rees, Head of Research, OPEN Health Patient & Brand Communication takes 15 minutes to answer some key questions on insights and market research in pharma

Early diagnosis underpins NHS cancer strategy

Paul Midgley, Oli Hudson and Sarah Shield, of Wilmington Healthcare, explore how the NHS is tackling cancer in line with the Long-term Plan

Launch Excellence 2020

In this special pack, we provide a comprehensive outlook of launch excellence. We cover topics ranging from gathering effective insights, to understanding the current landscape, and the importance of pre-launch...

OPEN Health reflections on the World Orphan Drug Congress in Barcelona

Having just returned from a very busy but hugely enjoyable few days at congress, I wanted to share our views on the event and key themes that our healthcare communications...

Antibiotic resistance: The silent pandemic

Porterhouse is proud to support World Antibiotic Awareness Week. Our article aims to improve awareness of one of the biggest threats to global health today: antibiotic resistance.

Insights from non-healthcare marketing: Brand Activism – does it have a role in Pharma?

Press Releases | November 14, 2019 | Resonant Group

Increasingly consumers are demanding that brands be more active – that they not only stand for something, but they do something about it.